MedPath

Immune Thrombocytopenia (ITP) Immune-Genetic Assessment

Conditions
Thrombocytopenia
Registration Number
NCT01196884
Lead Sponsor
Azienda Sanitaria-Universitaria Integrata di Udine
Brief Summary

Primary ITP has wide heterogenous biology, presentation and response to therapy.

The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
190
Inclusion Criteria
  • Adult patients with primary ITP
Exclusion Criteria
  • Secondary ITP

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (13)

Department of Hematology and Bone Marrow Transplantation Unit, Oncology Center Armando Businco

🇮🇹

Cagliari, Italy

UF Ematologia, Policlinico di Careggi

🇮🇹

Firenze, Italy

Department of Oncology/Haematology, Niguarda Ca'Granda Hospital

🇮🇹

Milano, Italy

Istituto di Immunologia, Dipartimento di Scienze Mediche dell'Università degli Studi del Piemonte Orientale "Amedeo Avogadro"

🇮🇹

Novara, Italy

Department of Medical and Surgical Sciences, University of Padova

🇮🇹

Padova, Italy

Oncology-Hematology Department, "S. Maria delle Croci" Hospital

🇮🇹

Ravenna, Italy

Ematologia, Ospedale Ca' Foncello

🇮🇹

Treviso, Italy

Ematologia, San Bortolo Hospital

🇮🇹

Vicenza, Italy

Institute of Hematology, Catholic University,

🇮🇹

Roma, Italy

Istituto di Ematologia L. & A. Seragnoli

🇮🇹

Bologna, Italy

U.O. Ematologia 2, IRCCS Cà Granda Ospedale Maggiore Policlinico

🇮🇹

Milano, Italy

Clinica Ematologica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi del Piemonte Orientale "Amedeo Avogadro

🇮🇹

Novara, Italy

Clinica Ematologica AOUD S. Maria Misericordia

🇮🇹

Udine, Italy

© Copyright 2025. All Rights Reserved by MedPath